Tutkijat / Oulu  | Ala-Kokko, L. |
| Ala-Kokko, T(ero) |
| Ala-Korpela, M(ika) |
| Alahuhta, S. |
| Alén, M(arkku) |
| Antikainen, R. |
| Anttonen, V(uokko) |
| Biancari, F(austo) |
| Bloigu, R(isto) |
| Eskelinen, S. |
| Flinkkilä, T(apio) |
| Hakkola, J. |
| Hallman, M. |
| Hartikainen, A(nna)-L(iisa) |
| Hausen, H. |
| Hautala, N(ina) |
| Hautala, T(imo) |
| Heape, A. |
| Herzig, K(arl)-H(einz) |
| Hillbom, M. |
| Hiltunen, J.K. |
| Hörkko, S. |
| Huikuri, H(eikki) |
| Hukkanen J(anne) |
| Ignatius, J. |
| Isohanni, M. |
| Jaakkola, J. |
| Jaakkola, M(aritta) S. |
| Jaakola, V-P. |
| Jämsä, T(imo) |
| Janhonen, S. |
| Jartti, T(uomas) |
| Järvelin, M(arjo)-R(iitta) |
| Jokelainen, J(ari) |
| Juffer, A(ndré) H. |
| Junttila, J(uhani) |
| Juvonen, T. |
| Kaarteenaho, R(iitta) |
| Kajantie, E(ero)*(THL/OY) |
| Karppinen (Koivunen), P(eppi) |
| Karppinen, J(aro) |
| Karttunen, T.J. |
| Keinänen-Kiukaanniemi, S(irkka) |
| Kerkelä, R(isto) |
| Kesäniemi, Y(rjö) A(ntero) |
| Kettunen, J(ohannes) |
| Kietzmann, T(homas). |
| Kivirikko, K.I. |
| Knuuttila, M. |
| Koivukangas, J. |
| Kursula, P(etri) |
| Kyngäs, H. |
| Larivaara, P. |
| Larmas, M. |
| Lehenkari, P(etri) |
| Lehtiö, L(ari) |
| Leppilahti, J. |
| Luukinen, H. |
| Mainio A |
| Majamaa, K. |
| Mäki, P(irjo) |
| Mäkikallio, T(imo) H. |
| Männikkö, M(inna) |
| Manninen, A(ki). |
| Martikainen, H(annu) |
| Miettunen, J(ouko) |
| Myllyharju, J(ohanna) |
| Myllylä, R. |
| Myllylä, V. |
| Näyhä, S(imo) |
| Neubauer, P. |
| Nieminen, M(iika) T. |
| Nieminen, P(entti) |
| Niinimäki, J(aakko) |
| Ohukainen, P(auli) |
| Oikarinen, A. |
| Oikarinen, K. |
| Pelkonen, O(lavi) |
| Petäjä-Repo, U.E. |
| Pihlajaniemi, T(aina) |
| Pirttiniemi, P(ertti) |
| Puistola, U(lla) |
| Rajaniemi, H.J. |
| Räsänen, P. |
| Raustia, A. |
| Remes, A(nne) |
| Risteli, J. |
| Ristiniemi, J. |
| Ruddock, L.W. |
| Ruokonen, A. |
| Ryynänen, M. |
| Saarakkala, S. |
| Saari, A. |
| Salo, T(uula) |
| Sándor, G(eorge) K. |
| Savolainen, E-R. |
| Savolainen, M.J. |
| Savolainen, O. |
| Sillanpää, M(ikko). |
| Soininen, R. |
| Sorri, M. |
| Taanila, A. |
| Tapiainen, T(erhi) |
| Tervonen, O(smo) |
| Timonen, M(arkku) |
| Turpeenniemi-Hujanen, T. |
| Tuukkanen, J(uha) |
| Tuulonen, A. |
| Uhari, M. |
| Ukkola, O(lavi) |
| Uusimaa, J. |
| Vainio, O. |
| Vainio, S. |
| Väyrynen, J(uha) P. |
| Veijola, J(uha) |
| Veijola, R(iitta) |
| Virokannas, H. |
| Voipio, H(anna)-M(arja) |
| Vuolteenaho, O. |
| Weckström, M. |
| Wei, GH. |
| Wierenga, R.K. |
| Winqvist, R(obert) |
| Ylänne, J. |
| Ylitalo, K(ari) |
Scholar Chart >>
|
»My Articles
»Latest Feeds
»Popular Feeds |
| | What is 'LDL cholesterol'? | Ala-Korpela, M(ika) | 1249 days | save |  |  | |
| Proof of concept for quantitative urine NMR metabolomics pipeline for large-scale epidemiology and genetics. | Ala-Korpela, M(ika) | 1252 days | save | | | |
| The effect of apolipoprotein E polymorphism on serum metabolome - a population-based 10-year follow-up study. | Ala-Korpela, M(ika) | 1254 days | save | | | |
| Biomarker Glycoprotein Acetyls Is Associated With the Risk of a Wide Spectrum of Incident Diseases and Stratifies Mortality Risk in Angiography Patients. | Ala-Korpela, M(ika) | 1291 days | save | | | |
| Metabolomic Consequences of Genetic Inhibition of PCSK9 Compared With Statin Treatment | Ala-Korpela, M(ika) | 1300 days | save | | | |
| Investigating the effects of lycopene and green tea on the metabolome of men at risk of prostate cancer: The ProDiet randomised controlled trial. | Ala-Korpela, M(ika) | 1356 days | save | | | |
| Circulating metabolic biomarkers of renal function in diabetic and non-diabetic populations. | Ala-Korpela, M(ika) | 1356 days | save | | | |
| Cognition, psychosis risk and metabolic measures in two adolescent birth cohorts. | Ala-Korpela, M(ika) | 1440 days | save | | | |
| Association of circulating metabolites with healthy diet and risk of cardiovascular disease: analysis of two cohort studies. | Ala-Korpela, M(ika) | 1488 days | save | | | |
| Circulating amino acids and the risk of macrovascular, microvascular and mortality outcomes in individuals with type 2 diabetes: results from the ADVANCE trial. | Ala-Korpela, M(ika) | 1518 days | save | | | |
| NAFLD risk alleles in PNPLA3, TM6SF2, GCKR, and LYPLAL1 show divergent metabolic effects. | Ala-Korpela, M(ika) | 1542 days | save | | | |
| Association of branched-chain amino acids and other circulating metabolites with risk of incident dementia and Alzheimer's disease: A prospective study in eight cohorts. | Ala-Korpela, M(ika) | 1577 days | save | | | |
| Identification of seven novel loci associated with amino acid levels using single variant and gene-based tests in 8,545 Finnish men from the METSIM study. | Ala-Korpela, M(ika) | 1588 days | save | | | |
| Lipids, Lipoproteins, and Metabolites and Risk of Myocardial Infarction and Stroke. | Ala-Korpela, M(ika) | 1606 days | save | | | |
| Metabolic characterization of menopause: cross-sectional and longitudinal evidence. | Ala-Korpela, M(ika) | 1608 days | save | | | |
| Effect of Dietary Counseling on a Comprehensive Metabolic Profile from Childhood to Adulthood. | Ala-Korpela, M(ika) | 1609 days | save | | | |
| Nuclear magnetic resonance-based metabolomics identifies phenylalanine as a novel predictor of incident heart failure hospitalisation: results from PROSPER and FINRISK 1997. | Ala-Korpela, M(ika) | 1665 days | save | | | |
| DHA mediates the protective effect of fish consumption on new episodes of depression among women. | Ala-Korpela, M(ika) | 1676 days | save | | | |
| Quantitative Serum Nuclear Magnetic Resonance Metabolomics in Large-Scale Epidemiology: A Primer on -Omic Technologies. | Ala-Korpela, M(ika) | 1700 days | save | | | |
| Common, low-frequency, and rare genetic variants associated with lipoprotein subclasses and triglyceride measures in Finnish men from the METSIM study. | Ala-Korpela, M(ika) | 1707 days | save | | | |
| Genetic Support for a Causal Role of Insulin Resistance on Circulating Branched-Chain Amino Acids and Inflammation. | Ala-Korpela, M(ika) | 1718 days | save | | | |
| Objective Metabolomics Research. | Ala-Korpela, M(ika) | 1719 days | save | | | |
| Differential Associations of Inflammatory Markers With Insulin Sensitivity and Secretion: The Prospective METSIM Study. | Ala-Korpela, M(ika) | 1752 days | save | | | |
| Association of pre-pregnancy body mass index with offspring metabolic profile: Analyses of 3 European prospective birth cohorts. | Ala-Korpela, M(ika) | 1776 days | save | | | |
| An interaction map of circulating metabolites, immune gene networks, and their genetic regulation. | Ala-Korpela, M(ika) | 1796 days | save | | | |
| Trans-ancestry Fine Mapping and Molecular Assays Identify Regulatory Variants at the ANGPTL8 HDL-C GWAS Locus. | Ala-Korpela, M(ika) | 1800 days | save | | | |
| Experimental and Human Evidence for Lipocalin-2 (Neutrophil Gelatinase-Associated Lipocalin [NGAL]) in the Development of Cardiac Hypertrophy and heart failure. | Ala-Korpela, M(ika) | 1844 days | save | | | |
| Mendelian randomization in cardiometabolic disease: challenges in evaluating causality. | Ala-Korpela, M(ika) | 1858 days | save | | | |
| Metabolic profiling of polycystic ovary syndrome reveals interactions with abdominal obesity. | Ala-Korpela, M(ika) | 1864 days | save | | | |
| Novel association of TM6SF2 rs58542926 genotype with increased serum tyrosine levels and decreased apolipoprotein B-100 particles in Finns. | Ala-Korpela, M(ika) | 1865 days | save | | | |
| Relationships between gut microbiota, plasma metabolites, and metabolic syndrome traits in the METSIM cohort. | Ala-Korpela, M(ika) | 1906 days | save | | | |
| Impaired HDL2-mediated cholesterol efflux is associated with metabolic syndrome in families with early onset coronary heart disease and low HDL-cholesterol level. | Ala-Korpela, M(ika) | 1963 days | save | | | |
| Epigenome-wide association study of body mass index, and the adverse outcomes of adiposity. | Ala-Korpela, M(ika) | 2020 days | save | | | |
| Metabolic profiling of pregnancy: cross-sectional and longitudinal evidence. | Ala-Korpela, M(ika) | 2028 days | save | | | |
| Blood hsa-miR-122-5p and hsa-miR-885-5p levels associate with fatty liver and related lipoprotein metabolism-The Young Finns Study. | Ala-Korpela, M(ika) | 2036 days | save | | | |
| Metabolic signatures of birthweight in 18 288 adolescents and adults. | Ala-Korpela, M(ika) | 2043 days | save | | | |
| Metabolic profiling-multitude of technologies with great research potential, but (when) will translation emerge? | Ala-Korpela, M(ika) | 2073 days | save | | | |
| Metabolomics in cardiovascular medicine: Not personalised, not diagnostic. | Ala-Korpela, M(ika) | 2073 days | save | | | |
| Metabolic profiling of fatty liver in young and middle-aged adults - cross-sectional and prospective analyses of the Young Finns Study. | Ala-Korpela, M(ika) | 2078 days | save | | | |
| Effect of metformin therapy on circulating amino acids in a randomized trial: the CAMERA study. | Ala-Korpela, M(ika) | 2085 days | save | | | |
| Characterization of the metabolic profile associated with serum 25-hydroxyvitamin D: a cross-sectional analysis in population-based data. | Ala-Korpela, M(ika) | 2124 days | save | | | |
| Variant rs10911021 that associates with coronary heart disease in type 2 diabetes, is associated with lower concentrations of circulating HDL cholesterol and large HDL particles but not with amino acids. | Ala-Korpela, M(ika) | 2140 days | save | | | |
| Effects of hormonal contraception on systemic metabolism: cross-sectional and longitudinal evidence. | Ala-Korpela, M(ika) | 2144 days | save | | | |
| Metabolic profiling of alcohol consumption in 9778 young adults. | Ala-Korpela, M(ika) | 2155 days | save | | | |
| Prompt impact of first prospective statin mega-trials on postoperative lipid management of CABG patients: a 20-year follow-up in a single hospital. | Ala-Korpela, M(ika) | 2167 days | save | | | |
| Metabolomics of aging requires large-scale longitudinal studies with replication. | Ala-Korpela, M(ika) | 2209 days | save | | | |
| metaCCA: summary statistics-based multivariate meta-analysis of genome-wide association studies using canonical correlation analysis. | Ala-Korpela, M(ika) | 2249 days | save | | | |
| The Biomarker GlycA Is Associated with Chronic Inflammation and Predicts Long-Term Risk of Severe Infection. | Ala-Korpela, M(ika) | 2253 days | save | | | |
| Metabolic Characterization of a Rare Genetic Variation within APOC3 and its Lipoprotein Lipase Independent Effects. | Ala-Korpela, M(ika) | 2259 days | save | | | |
| Prolonged sleep restriction induces changes in pathways involved in cholesterol metabolism and inflammatory responses. | Ala-Korpela, M(ika) | 2263 days | save | | | |
| | 
report | « prev page 3 next » | | |
|
